ReviewDisease models & mechanisms2022
The benefits, limitations and opportunities of preclinical models for neonatal drug development.
Sarah Campion et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it